Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 23 Feb 2015 for Bellerophon Therapeutics, Inc., €3.8M.
Insider track record
Disclosed buys
1
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
1
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Linde North America, Inc.: trading record in brief
Our data holds just one disclosure by Linde North America, Inc., dated 23 February 2015, reporting an open-market purchase worth €3.8M in Bellerophon Therapeutics, Inc. Further filings will be added here. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Linde North America, Inc.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
- 358,916 shares@ US$12.00Common StockSEC:0001104659-15-013147:0Canonical exit: 20 May 2015 (T+90)
1 of 1 declaration